# 12‑Month Roadmap — Symbolic First (PCS‑HELIO v4.3)

**Owner:** Demetrios Agourakis, MD (ORCID 0000-0002-8596-5097)  
**Scope:** Symbolic First (HELIO deferred); public data only; Q1–Q10 governance.  
**Date:** 2025-08-31

## Objectives
1) Deliver AG5/KEC as an interpretable cognitive biomarker (SWOW→KEC; ZuCo validation).
2) Produce two Q1 technical papers and two Q1 philosophical papers; open preprints + DOIs.
3) Ready-to-defend Master’s deliverables (figures, notebooks, toolbox, IMRaD manuscript).

## Milestones (M = month)
- M0 (this week): v4.3 structure locked; linkcheck=0; CI green.
- M1–2: ETL SWOW/ZuCo; KEC v0.1; F1–F3; Methods draft.
- M3–4: Mixed-effects (reading cost ~ KEC + controls); EEG bands; toolbox v0.2.
- M5–6: Tech Paper #1 (methods+validation) → preprint+DOI.
- M7–8: Biomarker refinement; sensitivity/ablations; clinical framing.
- M9: Tech Paper #2 (application) → preprint+DOI.
- M10–11: Philosophical papers (final consolidation) → preprints.
- M12: Master’s defense package (all artifacts reproducible).

## Clinical Relevance
KEC explains variance in reading effort and EEG power at fixation-level; interpretable edges/curvature support clinician-facing explanations (digital biomarker candidate).

## Deliverables & Acceptance
- Reproducible notebooks (01–04), toolbox v0.2, F1–F3 figures, IMRaD manuscript.
- Q1–Q10 checklist signed off; linkcheck=0; seeds/pins & provenance present.

## Risks & Mitigations
- Noisy EEG: robust preprocessing; cluster-robust SEs; band-aggregation.
- Overfitting: ablations (shuffles, degree-preserving), bootstraps + CIs.
- Scope creep: HELIO strictly deferred until Symbolic core is accepted.
